Shares of Telesis Bio, Inc. (NASDAQ: TBIO) are soaring on the US stock charts today, following the announcement of a significant partnership. In pre-market trading,
In an unexpected turn of events, Telesis Bio, Inc. (NASDAQ: TBIO) witnessed an extraordinary surge in its stock price, sending shockwaves through the market. The
The Translate Bio Inc. (TBIO) stock lost 22.10% in the pre-market trading on Thursday, March 18 2021 after TBIO announced the clinical trial results of
China Automotive Systems Inc. (CAAS) stock soared 2.38% to $10.75 in the pre-market trading after reporting that it shipped approximately 120,000 units from its portfolio
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.